In contrast, the more aggressive type of breast cancer known as triple-negative breast cancer (TNBC), which lacks the expression of ER, PR, and Her2, has been reported to have a higher tendency for metastasis, a poorer prognosis, and higher relapse rates compared to non-TNBC [32]. This evidence concerns the gene ERBB2 and breast carcinoma.